NEW MEXICO — The U.S. Supreme Court on Monday temporarily restored broad access to the abortion medication mifepristone, blocking a lower‑court ruling that would have imposed new restrictions nationwide.
The order, signed by Justice Samuel Alito, allows patients to continue obtaining mifepristone through telehealth, mail delivery, or pharmacies without requiring an in‑person doctor visit. Those rules had been in place for several years before a federal appeals court moved last week to limit access.
The decision has particular significance for New Mexico, where abortion remains legal under state law. Providers in the state rely heavily on medication abortions, which account for the majority of procedures nationwide. The ruling ensures that access in New Mexico continues without interruption during the legal review.
New Mexico has also seen an increase in patients traveling from neighboring states with abortion bans since the Supreme Court overturned Roe v. Wade in 2022. Medication abortions have remained a key option for both in‑state and out‑of‑state patients.
The legal challenge was brought by Louisiana, which argued that access to mifepristone undermines abortion restrictions in states with bans. Some Democratic‑led states, including New Mexico, have enacted laws protecting providers who prescribe abortion medication through telehealth, even to patients in states where abortion is restricted.
The Supreme Court’s order will remain in effect for at least one week while both sides submit additional legal arguments and the justices consider whether to take further action in the case. Manufacturers of mifepristone filed emergency appeals asking the Court to intervene after the appeals court ruling.
For now, New Mexico clinics and pharmacies can continue dispensing mifepristone under existing federal rules as the case moves forward.
